Posts tagged “N.C. Biotech Center”
Medicon - northern Europe's medical valley - meets RTP
Over the course of the two days, researchers shared their nanomedicine work on targeted drug delivery. Vaccine delivery. Drug toxicity. Scandinavians and North Carolinians shared the same language with the same terminology.
NC Biotech Center loans Chapel Hill vaccine firm $250,000
Chapel Hil-based Heat Biologics is in the midst of a fundraising round expected to raise $4.1 million to finance clinical trials.
Biotech Center awards $1 million in grants for university research
Scientists at NCSU, East Carolina and UNC-Wilmington receive $250,000 to fund work toward federal grant applications.
Drug startup NovaTarg targets hepatitis C
NovaTarg's research focuses on activating AMPK, an enzyme that regulates how cells use energy. The company says that its research with AMPK has applications in addressing liver diseases, diabetes and cancer.
Durham company gets $30K Biotech Center loan
NovaTarg, founded in Durham in 2009, is developing novel pharmaceutical products targeting liver diseases and diabetes.
Opinion: New life sciences cluster report presents skewed view of RTP's activities
The Triangle is outstanding for life sciences whether reports on U.S. markets score it first, last or in the middle.
Beyond the numbers: The real strength of NC's life science cluster
Opinion: A new report shows we have plenty of work to do to keep North Carolina competitive in this volatile life-science environment. We need to open new doors to bring in more venture and other funding, for example. But during these difficult global economic times we are thankful that we keep adding life-science jobs statewide and companies keep calling us to help them relocate their businesses to North Carolina.
More companies look to span farm, pharma worlds in NC
Biotechnology advances that boost crop yields and improve drought tolerance are well under way. But agbiotech research is also finding pharmaceutical applications, particularly for targeted drug delivery.
Just call Charles Hamner the 'biofather' of biotech in NC
A recipient of a North Carolina Award for public service, the longtime head of the N.C. Biotechnology Center says he was "shocked" by the honor. "I was lucky enough to come along at the right time when the biotechnology industry was being developed here," he adds. The Award says otherwise.
NC's 'biofather' sees more growth for biotech - and risks
Charles Hamner, who received a "North Carolina Award" for his efforts to establish and grow the biotechnology industry across North Carolina, sees "fantastic" potential for more growth. However, he's also concerned about capital, the training of future workers, and finding new leaders.
Pets, people win in regenerative health partnership
Analysis: Animals may get a new lease on life and health, while also helping in the development of human therapies. It's the upshot of a regenerative medicine partnership announced by officials of North Carolina State University and Wake Forest Baptist Medical Center.
IBM's 'Watson' supercomputer - Is it healthcare's future?
Dr. Watson? No. Just a tool. At NCSU biotech forum, an IBM exec says Watson can advance medical care and it will be controlled by the doctors.
NC Biotech Center names new board chairman
Architect and head of design firm John Atkins replaces venture capitalist Arthur Pappas.
Big news at biotech event may not be a jobs announcement
Gov. Bev Perdue could be announcing new life science jobs at the NCBIO annual meeting on Wednesday. But biotech executives are yearning for clarity in a muddled regulatory environment.
Japanese researchers unveil fat-derived stem cell uses
In displays at its NU Tech Regenerative Medicine Roundtable, Nagoya University showed off several applications its researchers have discovered for stem cells derived from adipose tissue other than bone marrow.







